ID: ALA3309939

Max Phase: Preclinical

Molecular Formula: C16H13Cl2N

Molecular Weight: 290.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)c1ccc(C#Cc2c(Cl)cccc2Cl)cc1

Standard InChI:  InChI=1S/C16H13Cl2N/c1-19(2)13-9-6-12(7-10-13)8-11-14-15(17)4-3-5-16(14)18/h3-7,9-10H,1-2H3

Standard InChI Key:  VLWPLFAVAFTRPL-UHFFFAOYSA-N

Associated Targets(Human)

LS174T 446 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.19Molecular Weight (Monoisotopic): 289.0425AlogP: 4.46#Rotatable Bonds: 1
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.77CX LogP: 5.41CX LogD: 5.41
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.70Np Likeness Score: -1.12

References

1. Sviripa VM, Zhang W, Kril LM, Liu AX, Yuan Y, Zhan CG, Liu C, Watt DS..  (2014)  Halogenated diarylacetylenes repress c-myc expression in cancer cells.,  24  (15): [PMID:24930834] [10.1016/j.bmcl.2014.04.113]

Source